基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Discover the complete record of transactions filed by Caggiano Anthony. Insider active across 1 company, notably Cognition Therapeutics INC. In total, 10 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 3 February 2023. The latest transaction was disclosed on 16 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Caggiano Anthony is Chief Medical Officer at Cognition Therapeutics INC, on the XNAS market. He has 10 filings in total, and across the 10 sampled recent filings between 2023-02-07 and 2026-04-20, the reported buy volume is EUR 9421, the sell volume is EUR 0, and the most frequent transaction nature is Attribution.